A Study to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Characteristics of LP-003 Injection in Participants With Wheat Allergy

by | Sep 11, 2026 | Clinical Trials | 0 comments

​ Conditions: Food Allergy; Wheat Hypersensitivity

Interventions: Biological: LP-003 Injection

Sponsors: Longbio Pharma (Suzhou) Co., Ltd.

Not yet recruiting Conditions: Food Allergy; Wheat Hypersensitivity
Interventions: Biological: LP-003 Injection
Sponsors: Longbio Pharma (Suzhou) Co., Ltd.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *